TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 1 | -1 | -4 | 12 | -2 | -44 | 0 | -8 |
S | %wins | 100 | 100 | 0 | 100 | 100 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/11 13:17 | 5/26/11 | CRTX | Cornerstone Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Roberts Alan | NC | O | VP,Scien | S | -44 | 7.60 | 0 | -6 | -8 | 68 | D | 13 | 44 | 33 | 48 | 15 | 20 | 12 | 10 | -1 | -4 | 12 | -2 | -44 | |
8/3/07 14:44 | 8/1/07 | ARGA | Auriga Laboratories, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roberts Alan | GA | O | Chief Sc | S | -4 | 0.8500 | 0 | -5 | -5 | 95 | D | ||||||||||||||
7/2/07 16:14 | 7/2/07 | ARGA | Auriga Laboratories, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roberts Alan | GA | O | Chief Sc | S | -5 | 1.07 | 0 | -5 | -5 | 100 | D | ||||||||||||||
6/5/07 17:22 | 6/1/07 | ARGA | Auriga Laboratories, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roberts Alan | GA | O | Chief Sc | S | -7 | 1.42 | 0 | -5 | -5 | 105 | D | ||||||||||||||
5/3/07 12:20 | 5/1/07 | ARGA | Auriga Laboratories, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roberts Alan | GA | O | Chief Sc | S | -7 | 1.37 | 0 | -5 | -4 | 110 | D | ||||||||||||||
4/4/07 12:08 | 4/2/07 | ARGA | Auriga Laboratories, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roberts Alan | GA | O | Chief Sc | S | -11 | 2.14 | 0 | -5 | -4 | 115 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |